Results 11 to 20 of about 14,077 (253)
Genomic aberrations in borderline ovarian tumors [PDF]
Journal of Translational Medicine, 2010 Background According to the scientific literature, less than 30 borderline ovarian tumors have been karyotyped and less than 100 analyzed for genomic imbalances by CGH.
Davidson Ben +8 more
doaj +4 more sources
Controversies in borderline ovarian tumors [PDF]
Journal of Gynecologic Oncology, 2015 Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete peritoneal resection of macroscopic lesions; in case of ...
Seong, Seok Ju +3 more
openaire +2 more sources
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Journal Obgin Emas, 2021 Ovarian borderline tumors are a group of pathologic tumors that exhibit a higher proliferative activity when compared to benign tumors. Due to the absence of a screening method, ovarian cancer is often diagnosed when the patient already has a complaint, or at an advanced stage.
Gistin Husnul Khatimah, Andi Friadi
openaire +1 more source
Management of borderline ovarian tumors
Annals of Oncology, 2016 Borderline ovarian tumors (BOT) are epithelial tumors of the ovaries with both malignant and non-malignant aspects. On the one hand, they are characterized by cellular proliferation and nuclear atypia but, on the other hand, they usually do not show infiltrative growth pattern.
A, du Bois +4 more
openaire +2 more sources
Borderline ovarian tumors [PDF]
Asia-Pacific Journal of Clinical Oncology, 2007 AbstractBorderline ovarian tumors account for approximately 15% of all epithelial ovarian tumors. In the early 1970s, borderline tumors were categorized as either serous or mucinous with overall survival rates of 75–90%. Since then, it has been recognized that the two categories are heterogonous.
Fatemeh GHAEMMAGHAMI +2 more
openaire +1 more source
BJS (British Journal of Surgery), EarlyView., 2020 Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä +18 more
wiley +1 more source
Borderline ovarian tumor and pregnancy
Romanian Journal of Medical Practice, 2019 We present a case of a 26 year-old pregnant woman, who was diagnosed a serous borderline tumor of the ovary, two years ago. CA 125, CA 19-9 and HE4 was within the normal range values. A Cystectomy was performed, where too histopathological diagnosis was decided.
Astrit M. Gashi +2 more
openaire +2 more sources
The Iraqi Journal of Medical Sciences, 2016 Background:Ovarian epithelial cancer is a leading cause of death among gynecological malignancies due mainly to advanced stage at presentation. Objectives:To investigate the expression of CD44v6 and p53 in borderline tumors and malignant ovarian surface
Mohanad M. Abdul Ghany +2 more
doaj +6 more sources
Endometriosis and ovarian cancer: Their association and relationship
European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2019 Objectives: To study endometriosis-associated borderline or malignant ovarian epithelial tumors by analyzing their differential clinical features, as well as the histological pattern, survival and immunohistochemical data compared with those without ...
Ernesto Bas-Esteve +4 more
doaj +1 more source